Home
Storia in 1 fonti
Pharmalittle: We're reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about
Raccontata da
statnews.com
Timeline cronologica
- ·
Pharmalittle: We're reading about FDA reforming clinical trials, a Pfizer setback, and much more news
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
- ·
Pharmalittle: We're reading about an FDA commissioner candidate, Germany's plans for drug prices, and more
Regenxbio plans to apply for accelerated approval for its gene therapy for Duchenne muscular dystrophy.
- ·
Pharmalittle: We're reading about weight loss drug spending, launch prices for medicines, and much more
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
- ·
Pharmalittle: We're reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about